Cargando…
Lower BAFF Levels in Myasthenic Patients Treated with Glucocorticoids
B-cell activating factor (BAFF), a member of tumor necrosis factor family, activates B cells, promotes their survival and proliferation. BAFF is considered to have an influence on development of autoimmune diseases including myasthenia gravis (MG). We aimed to evaluate BAFF serum levels in MG patien...
Autores principales: | Sobieszczuk, Ewa, Szczudlik, Piotr, Kubiszewska, Justyna, Szyluk, Beata, Lipowska, Marta, Dutkiewicz, Małgorzata, Kostera-Pruszczyk, Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8328853/ https://www.ncbi.nlm.nih.gov/pubmed/34338918 http://dx.doi.org/10.1007/s00005-021-00626-5 |
Ejemplares similares
-
Determinants of Quality of Life in Myasthenia Gravis Patients
por: Szczudlik, Piotr, et al.
Publicado: (2020) -
Prevalence and impact of autoimmune thyroid disease on myasthenia gravis course
por: Kubiszewska, Justyna, et al.
Publicado: (2016) -
Real World Evidence on the Effectiveness of Nusinersen within the National Program to Treat Spinal Muscular Atrophy in Poland
por: Krupa, Dominika, et al.
Publicado: (2023) -
Corrigendum: Pediatric CIDP: Diagnosis and Management. A Single-Center Experience
por: Łukawska, Małgorzata, et al.
Publicado: (2022) -
Pediatric CIDP: Diagnosis and Management. A Single-Center Experience
por: Łukawska, Małgorzata, et al.
Publicado: (2021)